📣 VC round data is live. Check it out!
- Public Comps
- THC Therapeutics
THC Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for THC Therapeutics and similar public comparables like Cerinnov Group, Greiffenberger, Fidia, Avsalt Group and more.
THC Therapeutics Overview
About THC Therapeutics
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Founded
2007
HQ

Employees
1
Website
Sectors
Financials (FY)
EV
$775K
Valuation Multiples
Start free trialTHC Therapeutics Stock Performance
THC Therapeutics has current market cap of $43K, and enterprise value of $775K.
THC Therapeutics' stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $775K | $43K | 0.0% | — | — | — | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTHC Therapeutics Valuation Multiples
THC Therapeutics Financial Valuation Multiples
As of May 16, 2026, THC Therapeutics has market cap of $43K and EV of $775K.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified THC Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


THC Therapeutics Competitors
THC Therapeutics competitors include Cerinnov Group, Greiffenberger, Fidia, Avsalt Group, DBT, ECOMB, Uztel and Grupul Industrial Electrocontact.
Most THC Therapeutics public comparables operate across Machinery.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.4x | — | (5.2x) | — | |||
| 0.1x | — | (5.1x) | — | |||
| (0.0x) | — | 0.0x | — | |||
| — | — | (1.2x) | — | |||
| 2.5x | 2.4x | (5.7x) | (4.7x) | |||
| 1.9x | — | (0.4x) | — | |||
This data is available for Pro users. Sign up to see all THC Therapeutics competitors and their valuation data. Start Free Trial | ||||||
THC Therapeutics M&A Activity
THC Therapeutics has acquired 1 company to date.
Last acquisition by THC Therapeutics was on July 9th 2025. THC Therapeutics acquired SugarTop Buddery for $3M (EV/Revenue multiple of ).
Latest Acquisitions by THC Therapeutics
| Description | SugarTop Buddery is a Vancouver-based cannabis dispensary specializing in craft flower strains and pre-rolled joints. The retailer sources products from licensed British Columbia cultivators like 7 Fingers and Broken Coast for indoor-grown indicas and sativas. SugarTop Buddery operates a physical store in East Vancouver with online ordering for recreational users aged 19 and older. |
| HQ Country | |
| HQ City | Eugene, OR |
| Deal Date | 9 Jul 2025 |
| Valuation | $3M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all THC Therapeutics acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout THC Therapeutics
| When was THC Therapeutics founded? | THC Therapeutics was founded in 2007. |
| Where is THC Therapeutics headquartered? | THC Therapeutics is headquartered in United States. |
| How many employees does THC Therapeutics have? | As of today, THC Therapeutics has over 1 employees. |
| Is THC Therapeutics publicly listed? | Yes, THC Therapeutics is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of THC Therapeutics? | THC Therapeutics trades under THCT ticker. |
| When did THC Therapeutics go public? | THC Therapeutics went public in 2007. |
| Who are competitors of THC Therapeutics? | THC Therapeutics main competitors include Cerinnov Group, Greiffenberger, Fidia, Avsalt Group, DBT, ECOMB, Uztel, Grupul Industrial Electrocontact. |
| What is the current market cap of THC Therapeutics? | THC Therapeutics' current market cap is $43K. |
| Is THC Therapeutics profitable? | No, THC Therapeutics is not profitable. |
| How many companies THC Therapeutics has acquired to date? | As of May 2026, THC Therapeutics has acquired 1 company. |
| What was the largest acquisition by THC Therapeutics? | $3M acquisition of SugarTop Buddery on 9th July 2025 was the largest M&A THC Therapeutics has done to date. |
| What companies THC Therapeutics acquired? | THC Therapeutics acquired SugarTop Buddery. |
| In how many companies THC Therapeutics has invested to date? | THC Therapeutics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to THC Therapeutics
Lists including THC Therapeutics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
